Randomized, phase 3 study of second-line tislelizumab versus chemotherapy in advanced or metastatic esophageal squamous cell carcinoma, RATIONALE 302: Asia subgroup. This is an ASCO Meeting Abstract ...
Correlation of LINE-1 hypomethylation with size and dysplasia in colorectal tubular adenomas, and risk for synchronous and metachronous CRC. Overall age-standardized rates for Colorectal Cancers (2004 ...
JUPITER-02: Randomized, double-blind, phase III study of toripalimab or placebo plus gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (NPC). This ...
Scope JCO publishes original research, reviews, and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, thoracic cancer, genitourinary ...
Palliative care service utilization and advance care planning issues for adult glioblastoma patients: A systematic review. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This ...
Risk factors and prophylaxis of irinotecan induced cholinergic syndrome in sight of supportive care. This is an ASCO Meeting Abstract from the 2017 Palliative and Supportive Care in Oncology Symposium ...